Evidence-Based Guidelines for the Pharmacological Management of Substance Misuse, Addiction and Comorbidity: Recommendations from the British Association for Psychopharmacology
- 1 September 2004
- journal article
- guideline
- Published by SAGE Publications in Journal of Psychopharmacology
- Vol. 18 (3) , 293-335
- https://doi.org/10.1177/026988110401800321
Abstract
No abstract availableKeywords
This publication has 326 references indexed in Scilit:
- The effect of sertraline and environmental context on treating depression and illicit substance use among methadone maintained opiate dependent patients: a controlled clinical trialDrug and Alcohol Dependence, 2004
- Drug Therapy for Alcohol DependenceNew England Journal of Medicine, 1999
- Alterations in Pharmacodynamics of Anxiolytics in Abstinent Alcoholic Men: Subjective Responses, Abuse Liability, and Electroencephalographic Effects of Alprazolam, Diazepam, and BuspironeThe Journal of Clinical Pharmacology, 1997
- The latent dimensionality of DIS/DSM-III-R nicotine dependence: exploratory analysesAddiction, 1996
- Is the Prescription of Amphetamine Justified as a Harm Reduction Measure?Journal of the Royal Society of Health, 1994
- The lack of efficacy of phenytoin in the prevention of recurrent alcohol-related seizuresAnnals of Emergency Medicine, 1994
- Assessment and management of opioid withdrawal symptoms in buprenorphine‐dependent subjectsBritish Journal of Addiction, 1992
- Emergency department treatment of alcohol withdrawal seizures with phenytoinAnnals of Emergency Medicine, 1991
- Five year outcome in patients withdrawn from long term treatment with diazepam.BMJ, 1990
- Wernicke's EncephalopathyNew England Journal of Medicine, 1985